Cargando…

Clinical, histological and molecular predictors of metastatic melanoma responses to anti-PD-1 immunotherapy

BACKGROUND: Prescribing anti-programmed death-1 (PD-1) immunotherapy for advanced melanoma is currently not restricted by any biomarker assessment. Determination of programmed death-ligand-1 (PD-L1)-expression status is technically challenging and is not mandatory, because negative tumours also achi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dupuis, Frantz, Lamant, Laurence, Gerard, Emilie, Torossian, Nouritza, Chaltiel, Leonor, Filleron, Thomas, Beylot-Barry, Marie, Dutriaux, Caroline, Prey, Sorilla, Gros, Audrey, Jullie, Marie-Laure, Meyer, Nicolas, Vergier, Béatrice
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048096/ https://www.ncbi.nlm.nih.gov/pubmed/29973670 http://dx.doi.org/10.1038/s41416-018-0168-9

Ejemplares similares

Real-World Survival in Patients with Metastatic Melanoma after Discontinuation of Anti-PD-1 Immunotherapy for Objective Response or Adverse Effects: A Retrospective Study
por: Valentin, Julie, et al.
Publicado: (2021)

Analysis of tumor response and clinical factors associated with vitiligo in patients receiving anti–programmed cell death-1 therapies for melanoma: A cross-sectional study
por: Dousset, Léa, et al.
Publicado: (2021)

Reintroduction of dabrafenib after previous vemurafenib-induced DRESS: Not always safe!
por: Luherne, Camille, et al.
Publicado: (2019)

Congenital haemangiomas: a single-centre retrospective review
por: Braun, Victoire, et al.
Publicado: (2020)

TP53 alterations in primary and secondary Sézary syndrome: A diagnostic tool for the assessment of malignancy in patients with erythroderma
por: Gros, Audrey, et al.
Publicado: (2017)

Immune checkpoint inhibitor rechallenge in patients who previously experienced immune-related inflammatory arthritis: a multicentre observational study
por: Ladouceur, Alexandra, et al.
Publicado: (2023)

Doxorubicin-induced loss of DNA topoisomerase II and DNMT1- dependent suppression of MiR-125b induces chemoresistance in ALK-positive cells
por: Congras, Annabelle, et al.
Publicado: (2018)

A High Programmed Cell Death Protein 1 Hormone Receptor Score on Skin Biopsy is Associated with Sézary Syndrome Diagnosis: A Study of 91 Patients with Erythroderma
por: LUHERNE, Camille, et al.
Publicado: (2022)

Integrative diagnosis of primary cutaneous large B-cell lymphomas supports the relevance of cell of origin profiling
por: Gros, Audrey, et al.
Publicado: (2022)

Positive Association Between Location of Melanoma, Ultraviolet Signature, Tumor Mutational Burden, and Response to Anti–PD-1 Therapy
por: Dousset, Léa, et al.
Publicado: (2021)

Successful rechallenge for severe lichenoid drug reaction to pembrolizumab presenting as “toxic epidermal necrolysis-like”
por: Eldani, Céline, et al.
Publicado: (2023)

Metastasis of Ciliary Body Melanoma to the Contralateral Eye: A Case Report and Review of Uveal Melanoma Literature
por: Torossian, Nouritza M., et al.
Publicado: (2015)

Combined Therapy with Anti-PD1 and BRAF and/or MEK Inhibitor for Advanced Melanoma: A Multicenter Cohort Study
por: Huynh, Sandra, et al.
Publicado: (2020)

Feasibility of comprehensive genotyping specimens from radial endobronchial ultrasonography and electromagnetic navigation bronchoscopy
por: Robin, Maxime, et al.
Publicado: (2021)

Clinical Development of Molecular Targeted Therapy in Head and Neck Squamous Cell Carcinoma
por: Gougis, Paul, et al.
Publicado: (2019)

CD158k and PD-1 expressions define heterogeneous subtypes of Sezary syndrome
por: Vergnolle, Inès, et al.
Publicado: (2022)

Sweet‐like syndrome and multiple COVID arm syndrome following COVID‐19 vaccines: ‘specific’ patterns in a series of 192 patients
por: Darrigade, Anne‐Sophie, et al.
Publicado: (2022)

Xenograft and cell culture models of Sézary syndrome reveal cell of origin diversity and subclonal heterogeneity
por: Poglio, Sandrine, et al.
Publicado: (2020)

Ultrarapid lytic granule release from CTLs activates Ca(2+)-dependent synaptic resistance pathways in melanoma cells
por: Filali, Liza, et al.
Publicado: (2022)

Online teaching of inflammatory skin pathology by a French-speaking International University Network
por: Perron, Emilie, et al.
Publicado: (2014)

Dissociated Responses in Patients with Metastatic Solid Tumors Treated with Immunotherapy
por: Vaflard, Pauline, et al.
Publicado: (2021)

Long-lasting cutaneous tuberculosis owing to Mycobacterium bovis masquerading as sarcoidosis
por: Dequidt, Laure, et al.
Publicado: (2018)

High endothelial venules (HEVs) in human melanoma lesions: Major gateways for tumor-infiltrating lymphocytes
por: Martinet, Ludovic, et al.
Publicado: (2012)

Targeting α-Synuclein for PD Therapeutics: A Pursuit on All Fronts
por: Teil, Margaux, et al.
Publicado: (2020)

Blockade of crizotinib-induced BCL2 elevation in ALK-positive anaplastic large cell lymphoma triggers autophagy associated with cell death
por: Torossian, Avedis, et al.
Publicado: (2019)

Recent Advances on Immunohistochemistry and Molecular Biology for the Diagnosis of Adnexal Sweat Gland Tumors
por: Macagno, Nicolas, et al.
Publicado: (2022)

Primary cutaneous peripheral T‐cell lymphomas with a T‐follicular helper phenotype: an integrative clinical, pathological and molecular case series study
por: Wang, Luojun, et al.
Publicado: (2022)

Is Infantile Hemangioma a Neuroendocrine Tumor?
por: Kaulanjan-Checkmodine, Priscilla, et al.
Publicado: (2022)

Impact of radiation on host immune system in patients treated with chemoradiotherapy and durvalumab consolidation for unresectable locally advanced non-small cell lung cancer
por: Pasquier, Corentin, et al.
Publicado: (2023)

Misconceptions and beliefs around hormone replacement therapy after childhood hematopoietic stem cell transplantation: A qualitative study among women leukemia survivors
por: Vergier, Julia, et al.
Publicado: (2023)

Estimations of overdiagnosis in breast cancer screening vary between 0% and over 50%: why?
por: Chaltiel, Dan, et al.
Publicado: (2021)

Expression of PD-1, PD-L1 and PD-L2 is associated with differentiation status and histological type of endometrial cancer
por: Mo, Zhongfu, et al.
Publicado: (2016)

Helical tomotherapy for post-mastectomy radiation therapy with or without breast implant: a single institution experience
por: Dejean, Romain, et al.
Publicado: (2022)

Molecular alterations and tumor suppressive function of the DUSP22 (Dual Specificity Phosphatase 22) gene in peripheral T-cell lymphoma subtypes
por: Mélard, Pierre, et al.
Publicado: (2016)

Cutaneous Involvement in Waldenström’s Macroglobulinaemia
por: STIEN, Sarah, et al.
Publicado: (2020)

Expression of PD-1 and PD-L1 increase in consecutive biopsies in patients with classical Hodgkin lymphoma
por: Hollander, Peter, et al.
Publicado: (2018)

Cutaneous necrotizing small‐vessel vasculitis induced by acute hepatitis E
por: Viallard, Jean‐François, et al.
Publicado: (2019)

Workshop on Surface Disordering : growth, roughening and phase transitions
por: Jullie, R
Publicado: (1992)

Histologic patterns of liver injury induced by anti-PD-1 therapy
por: Zhang, Dongwei, et al.
Publicado: (2019)

Evolutionary design of explainable algorithms for biomedical image segmentation
por: Cortacero, Kévin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_24hhuhgrv3odhs5ae9kdq3670p